Follicle Stimulating Hormone Receptor in Mesenchymal Stem Cells Integrates Effects of Glycoprotein Reproductive Hormones

Overview

Journal Ann N Y Acad Sci

Specialty Science

Date 2014 Aug 14

PMID 25118101

Citations 11

Authors

Irina L Tourkova

Michelle R Witt

La Li

Quitterie Larrouture

Li Liu

Jianhua Luo

Lisa J Robinson

Harry C Blair

Affiliations

Soon will be listed here.

Abstract

Previously we reported that follicle stimulating hormone (FSH) affects bone degradation in human cells and in follicle stimulating hormone receptor (FSH-R) null mice. Here we describe a FSH-R knockout bone-formation phenotype. We used mesenchymal stem cells (MSCs), osteoblast precursors that express FSH-R, to determine whether FSH regulates bone formation. FSH stimulates MSC cell adhesion 1-3 h and proliferation at 24 h after addition. On the basis of phylogenetic and clinical precedents, we also examined effects of pregnant levels of human chorionic gonadotropin (hCG) on MSCs. We found effects similar to those of FSH, and RNAi knockdown of FSH-R abrogated both FSH and hCG effects on MSCs. In contrast to effects on MSCs, neither FSH nor hCG had significant effects on osteoblast maturation. Also in MSCs, short-term treatment by FSH and hCG altered signaling pathways for proliferation, including Erk1/2 phosphorylation. Our results show augmentation of MSC proliferation by either FSH at menopausal levels or hCG at normal pregnant levels. We conclude that FSH-R participates in regulation of MSC precursor pools in response to either FSH or hCG, integrating the effects of these two glycoprotein hormones.

Citing Articles

The ecto-nucleotide pyrophosphatase/phosphodiesterase 2 promotes early osteoblast differentiation and mineralization in stromal stem cells.

Tourkova I, Larrouture Q, Liu S, Luo J, Schlesinger P, Blair H Am J Physiol Cell Physiol. 2024; 326(3):C843-C849.

PMID: 38223929 PMC: 11193479. DOI: 10.1152/ajpcell.00692.2023.

Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy?.

Cismaru C, Tomuleasa C, Jurj A, Chira S, Isachekcu E, Cismaru G Stem Cell Rev Rep. 2023; 20(1):206-217.

PMID: 37922107 DOI: 10.1007/s12015-023-10648-5.

Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype.

Cheung J, Lokman N, Abraham R, Macpherson A, Lee E, Grutzner F Int J Mol Sci. 2020; 22(1).

PMID: 33374698 PMC: 7793521. DOI: 10.3390/ijms22010071.

DEAD-Box Helicase 4 (Ddx4) Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers.

DOronzo S, Silvestris E, Lovero D, Cafforio P, Duda L, Cormio G Int J Mol Sci. 2020; 21(17).

PMID: 32847044 PMC: 7503840. DOI: 10.3390/ijms21176096.

FSH-metabolic circuitry and menopause.

Taneja C, Gera S, Kim S, Iqbal J, Yuen T, Zaidi M J Mol Endocrinol. 2019; 63(3):R73-R80.

PMID: 31454787 PMC: 6992500. DOI: 10.1530/JME-19-0152.

References

Blair H, Zaidi M, Huang C, Sun L . The developmental basis of skeletal cell differentiation and the molecular basis of major skeletal defects. Biol Rev Camb Philos Soc. 2008; 83(4):401-15. DOI: 10.1111/j.1469-185X.2008.00048.x. View

Vibede N, Hauser F, Williamson M, Grimmelikhuijzen C . Genomic organization of a receptor from sea anemones, structurally and evolutionarily related to glycoprotein hormone receptors from mammals. Biochem Biophys Res Commun. 1998; 252(2):497-501. DOI: 10.1006/bbrc.1998.9661. View

Rowland T, Miller L, Blaschke A, Doss E, Bonham A, Hikita S . Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev. 2009; 19(8):1231-40. DOI: 10.1089/scd.2009.0328. View

Simoni M, Khan S, Nieschlag E . Serum bioactive follicle-stimulating hormone-like activity in human pregnancy is a methodological artifact. J Clin Endocrinol Metab. 1991; 73(5):1118-22. DOI: 10.1210/jcem-73-5-1118. View

Dierich A, Sairam M, Monaco L, Fimia G, Gansmuller A, Lemeur M . Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci U S A. 1998; 95(23):13612-7. PMC: 24867. DOI: 10.1073/pnas.95.23.13612. View

Gurgan T, Montjean D, Demirol A, Menezo Y . Sequential (hFSH + recFSH) vs homogenous (hFSH or recFSH alone) stimulation: clinical and biochemical (cumulus cell gene expression) aspects. J Assist Reprod Genet. 2014; 31(6):657-65. PMC: 4048380. DOI: 10.1007/s10815-014-0208-1. View

Siraj A, Desestret V, Antoine M, Fromont G, Huerre M, Sanson M . Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases. BMC Cancer. 2013; 13:246. PMC: 3663659. DOI: 10.1186/1471-2407-13-246. View

Pawlikowski M, Winczyk K, Stepien H . Immunohistochemical detection of follicle stimulating hormone receptor (FSHR) in neuroendocrine tumours. Endokrynol Pol. 2013; 64(4):268-71. DOI: 10.5603/ep.2013.0004. View

Marians R, Ng L, Blair H, Unger P, Graves P, Davies T . Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci U S A. 2002; 99(24):15776-81. PMC: 137792. DOI: 10.1073/pnas.242322099. View

10.

Pricola K, Kuhn N, Haleem-Smith H, Song Y, Tuan R . Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem. 2009; 108(3):577-88. PMC: 2774119. DOI: 10.1002/jcb.22289. View

11.

Kumar R, Ijiri S, Trant J . Molecular biology of the channel catfish gonadotropin receptors: 2. Complementary DNA cloning, functional expression, and seasonal gene expression of the follicle-stimulating hormone receptor. Biol Reprod. 2001; 65(3):710-7. DOI: 10.1095/biolreprod65.3.710. View

12.

Chang P, Blair H, Zhao X, Chien Y, Chen D, Tilden A . Comparison of fetal and adult marrow stromal cells in osteogenesis with and without glucocorticoids. Connect Tissue Res. 2006; 47(2):67-76. DOI: 10.1080/03008200600584074. View

13.

Sun L, Peng Y, Sharrow A, Iqbal J, Zhang Z, Papachristou D . FSH directly regulates bone mass. Cell. 2006; 125(2):247-60. DOI: 10.1016/j.cell.2006.01.051. View

14.

Blair H, Wells A, Isales C . Pituitary glycoprotein hormone receptors in non-endocrine organs. Trends Endocrinol Metab. 2007; 18(6):227-33. DOI: 10.1016/j.tem.2007.06.001. View

15.

Lefevre G, Calipel A, Mouriaux F, Hecquet C, Malecaze F, Mascarelli F . Opposite long-term regulation of c-Myc and p27Kip1 through overactivation of Raf-1 and the MEK/ERK module in proliferating human choroidal melanoma cells. Oncogene. 2003; 22(55):8813-22. DOI: 10.1038/sj.onc.1207099. View

16.

Robinson L, Tourkova I, Wang Y, Sharrow A, Landau M, Yaroslavskiy B . FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts. Biochem Biophys Res Commun. 2010; 394(1):12-7. PMC: 2856932. DOI: 10.1016/j.bbrc.2010.02.112. View

17.

Allan C, Kalak R, Dunstan C, McTavish K, Zhou H, Handelsman D . Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci U S A. 2010; 107(52):22629-34. PMC: 3012495. DOI: 10.1073/pnas.1012141108. View

18.

Bogerd J, Granneman J, Schulz R, Vischer H . Fish FSH receptors bind LH: how to make the human FSH receptor to be more fishy?. Gen Comp Endocrinol. 2005; 142(1-2):34-43. DOI: 10.1016/j.ygcen.2004.12.008. View

19.

Iqbal J, Sun L, Kumar T, Blair H, Zaidi M . Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci U S A. 2006; 103(40):14925-30. PMC: 1595452. DOI: 10.1073/pnas.0606805103. View

20.

Robinson L, Mancarella S, Songsawad D, Tourkova I, Barnett J, Gill D . Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development. Lab Invest. 2012; 92(7):1071-83. PMC: 3387291. DOI: 10.1038/labinvest.2012.72. View